BioInformant

Your Global Leader in Stem Cell Market Research

The Countdown is On for Phacilitate Leaders World, part of Advanced Therapies Week, and the World Stem Cell Summit 2020

By

Each year, the BioInformant team enjoys participating in Phacilitate Leaders World, now part of Advanced Therapies Week, and the World Stem Cell Summit, which is co-hosted with the event.

Phacilitate Leaders World, part of Advanced Therapies Week 2020

This year’s conference is being held this year from Jan 21-24, 2020, in Miami, Florida, and will be the single largest networking event of the year, bringing together the entire ecosystem of the advanced therapies industry from across the globe.

If you can only attend one conference this year, I’d recommend this one because it attracts several thousand attendees, 350+ organizations, and 200+ speakers.

It’s also two events in one, because Phacilitate Leaders World (part of Advanced Therapies Week) is co-hosted with the World Stem Cell Summit, making it an opportunity to connect with new and existing clients and partners worldwide.

If your team is thinking to attend or sponsor, we received a code (“BIOINFORMANT“) for our community to get 10% off both delegate passes and event sponsorship.

Early bird registration discounts end on November 22, 2019, so if you act soon, you’ll get the best possible deal.

Will I see you there?

If you’re not able to make it, what other events are on your schedule for 2020? It’d be great to meet in person.

Cade

Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells)

By

  • Principal investigator Dr. Jaime Guevara Aguirre, world-renowned expert on growth hormone to conduct the trial of Altsulin® (Microencapsulated Sertoli Cells) in Laron Syndrome Patients

  • Laron Syndrome (aka Laron-type dwarfism) is a rare pediatric orphan disease eligible for the FDA “Golden Ticket”

  • Phase IIa proof-of-concept trial paves the way to commercial development of Sertoli Cells for the treatment of Type I Diabetes

[Read more…]

What is the difference between totipotent, pluripotent, and multipotent?

By

A common question is, what is the difference between totipotent, pluripotent, and multipotent cells? The answer is simple. Totipotent stem cells are the most versatile stem cell type, because they are formed shortly after fertilization of an egg cell by a sperm cell. They can become all of the cells of the human body, as well as the cells of the embryo and developing fetus.

At about four days into development, these totipotent cells specialize slightly, becoming pluripotent stem cells. [Read more…]

What are Stem Cells? | Everything You Need to Know About Stem Cells

By

Stem cells are undifferentiated cells that have the capacity to both differentiate and multiply into the 200 cells types that form a human being. In total, the human body is composed of an estimated 30 trillion cells, making stem cells extremely important to human development. Stem cells are also found in plants and animals.

The use of stem cells to treat human disease is being investigated within scientific research, as well as thousands of clinical trials worldwide. These cells are bringing hope to  many people worldwide, including patients, researchers, and clinicians.

For the bulk of human history, a serious injury or long-lasting disease meant death. Whether the problem was infection, degeneration or failure of a vital system, healers were at a loss for what to do. The problem? They couldn’t figure out how to replace systems that were damaged. This is where stem cells have the potential to create a paradigm shift.

What exactly are stem cells and how has are they changing the way that diseases and injuries are treated? [Read more…]

At the American Academy of Stem Cell Physicians Live Congress 2019, FDA Safety Panel Says No to the Bad Actors

By

*Photo: Dr. Warren Bleiweiss showing off new AASCP Board Certification.

The American Academy of Stem Cell Physicians hosted a panel on Nov. 2 to discuss safety standards for Physicians who practice stem cell medicine.

MIAMI, November 6, 2019 — The American Academy of Stem Cell Physicians (AASCP) was joined by the the alliance leader Janet Marchibroda in hosting a safety standards panel on November second at the AASCP Live Congress 2019. The panel, which was moderated by Janet Marchibroda, the president of The Alliance for cell therapy now, also attending via Skype Dr Peter Marks director of the Center for Biologics and Evaluation and Research, was well-received by physicians from around the world. [Read more…]

BioInformant's World-Class Clients